During the past decade, Klinikum Leverkusen; Med. Klinik III / Onkologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Leverkusen; Med. Klinik III / Onkologie" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Colorectal Neoplasms" (1 trials), "Gastrointestinal Cancers" (1 trials) and "Malignant Ascites" (1 trials). Many other conditions were trialed in "Klinikum Leverkusen; Med. Klinik III / Onkologie" in a lesser frequency.

Most popular intervention types in "Klinikum Leverkusen; Med. Klinik III / Onkologie" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Herceptin" (1 trials) and "Leucovorin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Leverkusen; Med. Klinik III / Onkologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Leverkusen; Med. Klinik III / Onkologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinikum Leverkusen; Med. Klinik III / Onkologie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Leverkusen; Med. Klinik III / Onkologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".